IMP3-saRNA Vaccine in Advanced NSCLC

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West China Hospital, Sichuan University, Chengdu, Sichuan, Chengdu, Sichuan, China
Contact: Study coordinator (West China Hospital Chengdu) · pxx2014@163.com · +86 18980606753

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Metastatic Hepatocellular Carcinoma · Local Advanced Hepatocellular Carcinoma · Alpha-fetoprotein (AFP)-Producing Gastric Cancer

Abroad (travel likely)RecruitingPHASE1

Goodyear, United States · Duarte, United States

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Rochester, United States · Rochester, United States

A Study of VET3-TGI in Patients With Solid Tumors

Solid Tumor, Adult · Microsatellite Stable Colorectal Cancer · Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Orange, United States

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Early Stage Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Philadelphia, United States